Biotechnology company Omega Therapeutics hit Chapter 11 bankruptcy in Delaware on Monday, listing more than $140 million in debt on its petition. The company also filed a form with the U.S. Securities ...

Omega Therapeutics , Inc. (NASDAQ:OMGA), a biotechnology firm with a market capitalization of $13.45 million, has secured debtor-in-possession (DIP) financing following its voluntary Chapter 11 ...

Gritstone bio (NASDAQ:GRTS) has filed for Chapter 11 bankruptcy protection in Delaware ... Shares of the cash-strapped ...